APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Patent Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chinese Patent Medicine Market Analysis and Forecast 2026-2032

20 December 2025202 pages

Choose your research edition.

Industry ResearchChinese Patent Medicine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Patent Medicine Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Chinese Patent Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Patent Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Patent Medicine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Chinese Patent Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Chinese Patent Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chinese Patent Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chinese Patent Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chinese Patent Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Chinese Patent Medicine include Chongqing Pharmaceutical Co., Ltd, China Pharmaceutical Group Corporation, Xinhualu Anti-Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Shijiazhuang Pharmaceutical Group Co., Ltd., Shanghai Pharmaceutical (Group) Co., Ltd., Nanjing Pharmaceutical Co., Ltd and Nanjing Pharmaceutical Industry (Group) Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Chinese Patent Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chinese Patent Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Chinese Patent Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chinese Patent Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chinese Patent Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Chinese Patent Medicine sales, projected growth trends, production technology, application and end-user industry.

Chinese Patent Medicine Segment by Company

Chongqing Pharmaceutical Co., Ltd

China Pharmaceutical Group Corporation

Xinhualu Anti-Pharmaceutical Group Co., Ltd.

Tianjin Pharmaceutical Group Co., Ltd.

Taiji Group Co., Ltd.

Shijiazhuang Pharmaceutical Group Co., Ltd.

Shanghai Pharmaceutical (Group) Co., Ltd.

Nanjing Pharmaceutical Co., Ltd

Nanjing Pharmaceutical Industry (Group) Co., Ltd.

Jiangxi Pharmaceutical Group Corporation

Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

North China Pharmaceutical Group Co., Ltd.

Hangzhou Huadong Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd

Guangzhou Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group Co., Ltd.

Chinese Patent Medicine Segment by Type

Liquid

Tablet

Syrup

Others

Chinese Patent Medicine Segment by Application

Online Sales

Offline Sales

Chinese Patent Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Patent Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Patent Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Patent Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Chinese Patent Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chinese Patent Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chinese Patent Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Syrup Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Chinese Patent Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Online Sales Major Manufacturers Table 8. Offline Sales Major Manufacturers Table 9. Chinese Patent Medicine Industry Trends Table 10. Chinese Patent Medicine Industry Drivers Table 11. Chinese Patent Medicine Industry Opportunities and Challenges Table 12. Chinese Patent Medicine Industry Restraints Table 13. Global Chinese Patent Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Chinese Patent Medicine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Chinese Patent Medicine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Chinese Patent Medicine Revenue Market Share by Region (2021-2026) Table 17. Global Chinese Patent Medicine Revenue Market Share by Region (2027-2032) Table 18. Global Chinese Patent Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 19. Global Chinese Patent Medicine Sales by Region (2021-2026) & (k tons) Table 20. Global Chinese Patent Medicine Sales by Region (2027-2032) & (k tons) Table 21. Global Chinese Patent Medicine Sales Market Share by Region (2021-2026) Table 22. Global Chinese Patent Medicine Sales Market Share by Region (2027-2032) Table 23. Global Chinese Patent Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Chinese Patent Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Chinese Patent Medicine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Chinese Patent Medicine Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global Chinese Patent Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Chinese Patent Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Chinese Patent Medicine Manufacturers, Product Type & Application Table 31. Global Chinese Patent Medicine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Chinese Patent Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Chinese Patent Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Chinese Patent Medicine Revenue Market Share by Type (2021-2026) Table 38. Global Chinese Patent Medicine Revenue Market Share by Type (2027-2032) Table 39. Global Chinese Patent Medicine Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 40. Global Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 41. Global Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 42. Global Chinese Patent Medicine Sales Market Share by Type (2021-2026) Table 43. Global Chinese Patent Medicine Sales Market Share by Type (2027-2032) Table 44. Global Chinese Patent Medicine Price by Type (2021-2026) & (US$/ton) Table 45. Global Chinese Patent Medicine Price by Type (2027-2032) & (US$/ton) Table 46. Global Chinese Patent Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Chinese Patent Medicine Revenue Market Share by Application (2021-2026) Table 50. Global Chinese Patent Medicine Revenue Market Share by Application (2027-2032) Table 51. Global Chinese Patent Medicine Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 52. Global Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 53. Global Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 54. Global Chinese Patent Medicine Sales Market Share by Application (2021-2026) Table 55. Global Chinese Patent Medicine Sales Market Share by Application (2027-2032) Table 56. Global Chinese Patent Medicine Price by Application (2021-2026) & (US$/ton) Table 57. Global Chinese Patent Medicine Price by Application (2027-2032) & (US$/ton) Table 58. Chongqing Pharmaceutical Co., Ltd Company Information Table 59. Chongqing Pharmaceutical Co., Ltd Business Overview Table 60. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 62. Chongqing Pharmaceutical Co., Ltd Recent Development Table 63. China Pharmaceutical Group Corporation Company Information Table 64. China Pharmaceutical Group Corporation Business Overview Table 65. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 67. China Pharmaceutical Group Corporation Recent Development Table 68. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information Table 69. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview Table 70. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 72. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development Table 73. Tianjin Pharmaceutical Group Co., Ltd. Company Information Table 74. Tianjin Pharmaceutical Group Co., Ltd. Business Overview Table 75. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 77. Tianjin Pharmaceutical Group Co., Ltd. Recent Development Table 78. Taiji Group Co., Ltd. Company Information Table 79. Taiji Group Co., Ltd. Business Overview Table 80. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 82. Taiji Group Co., Ltd. Recent Development Table 83. Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information Table 84. Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview Table 85. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 87. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development Table 88. Shanghai Pharmaceutical (Group) Co., Ltd. Company Information Table 89. Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview Table 90. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 92. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development Table 93. Nanjing Pharmaceutical Co., Ltd Company Information Table 94. Nanjing Pharmaceutical Co., Ltd Business Overview Table 95. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 97. Nanjing Pharmaceutical Co., Ltd Recent Development Table 98. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information Table 99. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview Table 100. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 102. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development Table 103. Jiangxi Pharmaceutical Group Corporation Company Information Table 104. Jiangxi Pharmaceutical Group Corporation Business Overview Table 105. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 107. Jiangxi Pharmaceutical Group Corporation Recent Development Table 108. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information Table 109. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview Table 110. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 112. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development Table 113. North China Pharmaceutical Group Co., Ltd. Company Information Table 114. North China Pharmaceutical Group Co., Ltd. Business Overview Table 115. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 117. North China Pharmaceutical Group Co., Ltd. Recent Development Table 118. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information Table 119. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview Table 120. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 122. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development Table 123. Harbin Pharmaceutical Group Co., Ltd Company Information Table 124. Harbin Pharmaceutical Group Co., Ltd Business Overview Table 125. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 126. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio Table 127. Harbin Pharmaceutical Group Co., Ltd Recent Development Table 128. Guangzhou Pharmaceutical Group Co., Ltd. Company Information Table 129. Guangzhou Pharmaceutical Group Co., Ltd. Business Overview Table 130. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 131. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 132. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development Table 133. Northeast Pharmaceutical Group Co., Ltd. Company Information Table 134. Northeast Pharmaceutical Group Co., Ltd. Business Overview Table 135. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 136. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 137. Northeast Pharmaceutical Group Co., Ltd. Recent Development Table 138. North America Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 141. North America Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 142. North America Chinese Patent Medicine Sales Price by Type (2021-2026) & (US$/ton) Table 143. North America Chinese Patent Medicine Sales Price by Type (2027-2032) & (US$/ton) Table 144. North America Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 147. North America Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 148. North America Chinese Patent Medicine Sales Price by Application (2021-2026) & (US$/ton) Table 149. North America Chinese Patent Medicine Sales Price by Application (2027-2032) & (US$/ton) Table 150. North America Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Chinese Patent Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Chinese Patent Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 154. North America Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 155. North America Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 156. North America Chinese Patent Medicine Sales Price by Country (2021-2026) & (US$/ton) Table 157. North America Chinese Patent Medicine Sales Price by Country (2027-2032) & (US$/ton) Table 158. United States Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 159. Canada Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 160. Mexico Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 161. Europe Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 164. Europe Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 165. Europe Chinese Patent Medicine Sales Price by Type (2021-2026) & (US$/ton) Table 166. Europe Chinese Patent Medicine Sales Price by Type (2027-2032) & (US$/ton) Table 167. Europe Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 170. Europe Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 171. Europe Chinese Patent Medicine Sales Price by Application (2021-2026) & (US$/ton) Table 172. Europe Chinese Patent Medicine Sales Price by Application (2027-2032) & (US$/ton) Table 173. Europe Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Chinese Patent Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Chinese Patent Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 177. Europe Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 178. Europe Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 179. Europe Chinese Patent Medicine Sales Price by Country (2021-2026) & (US$/ton) Table 180. Europe Chinese Patent Medicine Sales Price by Country (2027-2032) & (US$/ton) Table 181. Germany Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 182. France Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 183. U.K. Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 184. Italy Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 185. Russia Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 186. Spain Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 189. Sweden Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 190. Poland Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 191. China Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 192. China Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 193. China Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 194. China Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 195. China Chinese Patent Medicine Sales Price by Type (2021-2026) & (US$/ton) Table 196. China Chinese Patent Medicine Sales Price by Type (2027-2032) & (US$/ton) Table 197. China Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 198. China Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 199. China Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 200. China Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 201. China Chinese Patent Medicine Sales Price by Application (2021-2026) & (US$/ton) Table 202. China Chinese Patent Medicine Sales Price by Application (2027-2032) & (US$/ton) Table 203. Asia Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 206. Asia Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 207. Asia Chinese Patent Medicine Sales Price by Type (2021-2026) & (US$/ton) Table 208. Asia Chinese Patent Medicine Sales Price by Type (2027-2032) & (US$/ton) Table 209. Asia Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 212. Asia Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 213. Asia Chinese Patent Medicine Sales Price by Application (2021-2026) & (US$/ton) Table 214. Asia Chinese Patent Medicine Sales Price by Application (2027-2032) & (US$/ton) Table 215. Asia Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Chinese Patent Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Chinese Patent Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 219. Asia Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 220. Asia Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 221. Asia Chinese Patent Medicine Sales Price by Country (2021-2026) & (US$/ton) Table 222. Asia Chinese Patent Medicine Sales Price by Country (2027-2032) & (US$/ton) Table 223. Japan Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 224. South Korea Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 225. India Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 226. Australia Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Chinese Patent Medicine Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Chinese Patent Medicine Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Chinese Patent Medicine Sales by Type (2021-2026) & (k tons) Table 232. SAMEA Chinese Patent Medicine Sales by Type (2027-2032) & (k tons) Table 233. SAMEA Chinese Patent Medicine Sales Price by Type (2021-2026) & (US$/ton) Table 234. SAMEA Chinese Patent Medicine Sales Price by Type (2027-2032) & (US$/ton) Table 235. SAMEA Chinese Patent Medicine Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Chinese Patent Medicine Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Chinese Patent Medicine Sales by Application (2021-2026) & (k tons) Table 238. SAMEA Chinese Patent Medicine Sales by Application (2027-2032) & (k tons) Table 239. SAMEA Chinese Patent Medicine Sales Price by Application (2021-2026) & (US$/ton) Table 240. SAMEA Chinese Patent Medicine Sales Price by Application (2027-2032) & (US$/ton) Table 241. SAMEA Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Chinese Patent Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Chinese Patent Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 245. SAMEA Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 246. SAMEA Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 247. SAMEA Chinese Patent Medicine Sales Price by Country (2021-2026) & (US$/ton) Table 248. SAMEA Chinese Patent Medicine Sales Price by Country (2027-2032) & (US$/ton) Table 249. Brazil Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 250. Argentina Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 251. Chile Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 252. Colombia Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 253. Peru Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 255. Israel Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 256. UAE Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 257. Turkey Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 258. Iran Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 259. Egypt Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Chinese Patent Medicine Distributors List Table 263. Chinese Patent Medicine Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Chinese Patent Medicine Image Figure 2. Global Chinese Patent Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Patent Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Image Figure 5. Tablet Image Figure 6. Syrup Image Figure 7. Others Image Figure 8. Global Chinese Patent Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Chinese Patent Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Online Sales Image Figure 11. Offline Sales Image Figure 12. Global Chinese Patent Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Chinese Patent Medicine Revenue (2021-2032) & (US$ Million) Figure 14. Global Chinese Patent Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Chinese Patent Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Chinese Patent Medicine Revenue Market Share by Region (2021-2032) Figure 17. Global Chinese Patent Medicine Sales (2021-2032) & (k tons) Figure 18. Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 19. Global Chinese Patent Medicine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Chinese Patent Medicine Sales YoY (2021-2032) & (k tons) Figure 21. Europe Chinese Patent Medicine Sales YoY (2021-2032) & (k tons) Figure 22. China Chinese Patent Medicine Sales YoY (2021-2032) & (k tons) Figure 23. Asia (Excluding China) Chinese Patent Medicine Sales YoY (2021-2032) & (k tons) Figure 24. South America, Middle East and Africa Chinese Patent Medicine Sales YoY (2021-2032) & (k tons) Figure 25. Global Chinese Patent Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Chinese Patent Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Chinese Patent Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Chinese Patent Medicine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Chinese Patent Medicine Revenue Market Share by Type (2021-2032) Figure 31. Global Chinese Patent Medicine Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 32. Global Chinese Patent Medicine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Chinese Patent Medicine Sales Market Share by Type (2021-2032) Figure 34. Global Chinese Patent Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Chinese Patent Medicine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Chinese Patent Medicine Revenue Market Share by Application (2021-2032) Figure 37. Global Chinese Patent Medicine Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 38. Global Chinese Patent Medicine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Chinese Patent Medicine Sales Market Share by Application (2021-2032) Figure 40. North America Chinese Patent Medicine Revenue Share by Type (2021-2032) Figure 41. North America Chinese Patent Medicine Sales Share by Type (2021-2032) Figure 42. North America Chinese Patent Medicine Revenue Share by Application (2021-2032) Figure 43. North America Chinese Patent Medicine Sales Share by Application (2021-2032) Figure 44. North America Chinese Patent Medicine Revenue Share by Country (2021-2032) Figure 45. North America Chinese Patent Medicine Sales Share by Country (2021-2032) Figure 46. Europe Chinese Patent Medicine Revenue Share by Type (2021-2032) Figure 47. Europe Chinese Patent Medicine Sales Share by Type (2021-2032) Figure 48. Europe Chinese Patent Medicine Revenue Share by Application (2021-2032) Figure 49. Europe Chinese Patent Medicine Sales Share by Application (2021-2032) Figure 50. Europe Chinese Patent Medicine Revenue Share by Country (2021-2032) Figure 51. Europe Chinese Patent Medicine Sales Share by Country (2021-2032) Figure 52. China Chinese Patent Medicine Revenue Share by Type (2021-2032) Figure 53. China Chinese Patent Medicine Sales Share by Type (2021-2032) Figure 54. China Chinese Patent Medicine Revenue Share by Application (2021-2032) Figure 55. China Chinese Patent Medicine Sales Share by Application (2021-2032) Figure 56. Asia Chinese Patent Medicine Revenue Share by Type (2021-2032) Figure 57. Asia Chinese Patent Medicine Sales Share by Type (2021-2032) Figure 58. Asia Chinese Patent Medicine Revenue Share by Application (2021-2032) Figure 59. Asia Chinese Patent Medicine Sales Share by Application (2021-2032) Figure 60. Asia Chinese Patent Medicine Revenue Share by Country (2021-2032) Figure 61. Asia Chinese Patent Medicine Sales Share by Country (2021-2032) Figure 62. SAMEA Chinese Patent Medicine Revenue Share by Type (2021-2032) Figure 63. SAMEA Chinese Patent Medicine Sales Share by Type (2021-2032) Figure 64. SAMEA Chinese Patent Medicine Revenue Share by Application (2021-2032) Figure 65. SAMEA Chinese Patent Medicine Sales Share by Application (2021-2032) Figure 66. SAMEA Chinese Patent Medicine Revenue Share by Country (2021-2032) Figure 67. SAMEA Chinese Patent Medicine Sales Share by Country (2021-2032) Figure 68. Chinese Patent Medicine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Chinese Patent Medicine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Tablet
  • Syrup
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Chongqing Pharmaceutical Co., Ltd
  • China Pharmaceutical Group Corporation
  • Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  • Tianjin Pharmaceutical Group Co., Ltd.
  • Taiji Group Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Co., Ltd.
  • Shanghai Pharmaceutical (Group) Co., Ltd.
  • Nanjing Pharmaceutical Co., Ltd
  • Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  • Jiangxi Pharmaceutical Group Corporation
  • Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  • North China Pharmaceutical Group Co., Ltd.
  • Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd
  • Guangzhou Pharmaceutical Group Co., Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chinese Patent Medicine Market by Type
  3. 1.2.1 Global Chinese Patent Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid
  5. 1.2.3 Tablet
  6. 1.2.4 Syrup
  7. 1.2.5 Others
  8. 1.3 Chinese Patent Medicine Market by Application
  9. 1.3.1 Global Chinese Patent Medicine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Online Sales
  11. 1.3.3 Offline Sales
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Chinese Patent Medicine Market Dynamics
  1. 2.1 Chinese Patent Medicine Industry Trends
  2. 2.2 Chinese Patent Medicine Industry Drivers
  3. 2.3 Chinese Patent Medicine Industry Opportunities and Challenges
  4. 2.4 Chinese Patent Medicine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Chinese Patent Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Chinese Patent Medicine Revenue by Region
  3. 3.2.1 Global Chinese Patent Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chinese Patent Medicine Revenue by Region (2021-2026)
  5. 3.2.3 Global Chinese Patent Medicine Revenue by Region (2027-2032)
  6. 3.2.4 Global Chinese Patent Medicine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Chinese Patent Medicine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Chinese Patent Medicine Sales by Region
  9. 3.4.1 Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Chinese Patent Medicine Sales by Region (2021-2026)
  11. 3.4.3 Global Chinese Patent Medicine Sales by Region (2027-2032)
  12. 3.4.4 Global Chinese Patent Medicine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Chinese Patent Medicine Revenue by Manufacturers
  2. 4.1.1 Global Chinese Patent Medicine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Chinese Patent Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Chinese Patent Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chinese Patent Medicine Sales by Manufacturers
  6. 4.2.1 Global Chinese Patent Medicine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Chinese Patent Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Chinese Patent Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Chinese Patent Medicine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Chinese Patent Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Chinese Patent Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Chinese Patent Medicine Manufacturers, Product Type & Application
  13. 4.7 Global Chinese Patent Medicine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Chinese Patent Medicine Market CR5 and HHI
  16. 4.8.2 2025 Chinese Patent Medicine Tier 1, Tier 2, and Tier 3
5 Chinese Patent Medicine Market by Type
  1. 5.1 Global Chinese Patent Medicine Revenue by Type
  2. 5.1.1 Global Chinese Patent Medicine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Chinese Patent Medicine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Chinese Patent Medicine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Chinese Patent Medicine Sales by Type
  6. 5.2.1 Global Chinese Patent Medicine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chinese Patent Medicine Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Chinese Patent Medicine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Chinese Patent Medicine Price by Type
6 Chinese Patent Medicine Market by Application
  1. 6.1 Global Chinese Patent Medicine Revenue by Application
  2. 6.1.1 Global Chinese Patent Medicine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Chinese Patent Medicine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Chinese Patent Medicine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Chinese Patent Medicine Sales by Application
  6. 6.2.1 Global Chinese Patent Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Chinese Patent Medicine Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Chinese Patent Medicine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Chinese Patent Medicine Price by Application
7 Company Profiles
  1. 7.1 Chongqing Pharmaceutical Co., Ltd
  2. 7.1.1 Chongqing Pharmaceutical Co., Ltd Company Information
  3. 7.1.2 Chongqing Pharmaceutical Co., Ltd Business Overview
  4. 7.1.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  6. 7.1.5 Chongqing Pharmaceutical Co., Ltd Recent Developments
  7. 7.2 China Pharmaceutical Group Corporation
  8. 7.2.1 China Pharmaceutical Group Corporation Company Information
  9. 7.2.2 China Pharmaceutical Group Corporation Business Overview
  10. 7.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  12. 7.2.5 China Pharmaceutical Group Corporation Recent Developments
  13. 7.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  14. 7.3.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
  15. 7.3.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview
  16. 7.3.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  18. 7.3.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
  19. 7.4 Tianjin Pharmaceutical Group Co., Ltd.
  20. 7.4.1 Tianjin Pharmaceutical Group Co., Ltd. Company Information
  21. 7.4.2 Tianjin Pharmaceutical Group Co., Ltd. Business Overview
  22. 7.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  24. 7.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
  25. 7.5 Taiji Group Co., Ltd.
  26. 7.5.1 Taiji Group Co., Ltd. Company Information
  27. 7.5.2 Taiji Group Co., Ltd. Business Overview
  28. 7.5.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  30. 7.5.5 Taiji Group Co., Ltd. Recent Developments
  31. 7.6 Shijiazhuang Pharmaceutical Group Co., Ltd.
  32. 7.6.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
  33. 7.6.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview
  34. 7.6.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  36. 7.6.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
  37. 7.7 Shanghai Pharmaceutical (Group) Co., Ltd.
  38. 7.7.1 Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
  39. 7.7.2 Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview
  40. 7.7.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  42. 7.7.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
  43. 7.8 Nanjing Pharmaceutical Co., Ltd
  44. 7.8.1 Nanjing Pharmaceutical Co., Ltd Company Information
  45. 7.8.2 Nanjing Pharmaceutical Co., Ltd Business Overview
  46. 7.8.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  48. 7.8.5 Nanjing Pharmaceutical Co., Ltd Recent Developments
  49. 7.9 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  50. 7.9.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
  51. 7.9.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview
  52. 7.9.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  54. 7.9.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
  55. 7.10 Jiangxi Pharmaceutical Group Corporation
  56. 7.10.1 Jiangxi Pharmaceutical Group Corporation Company Information
  57. 7.10.2 Jiangxi Pharmaceutical Group Corporation Business Overview
  58. 7.10.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  60. 7.10.5 Jiangxi Pharmaceutical Group Corporation Recent Developments
  61. 7.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  62. 7.11.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
  63. 7.11.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview
  64. 7.11.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  66. 7.11.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
  67. 7.12 North China Pharmaceutical Group Co., Ltd.
  68. 7.12.1 North China Pharmaceutical Group Co., Ltd. Company Information
  69. 7.12.2 North China Pharmaceutical Group Co., Ltd. Business Overview
  70. 7.12.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  72. 7.12.5 North China Pharmaceutical Group Co., Ltd. Recent Developments
  73. 7.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  74. 7.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
  75. 7.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview
  76. 7.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  78. 7.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
  79. 7.14 Harbin Pharmaceutical Group Co., Ltd
  80. 7.14.1 Harbin Pharmaceutical Group Co., Ltd Company Information
  81. 7.14.2 Harbin Pharmaceutical Group Co., Ltd Business Overview
  82. 7.14.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
  84. 7.14.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments
  85. 7.15 Guangzhou Pharmaceutical Group Co., Ltd.
  86. 7.15.1 Guangzhou Pharmaceutical Group Co., Ltd. Company Information
  87. 7.15.2 Guangzhou Pharmaceutical Group Co., Ltd. Business Overview
  88. 7.15.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  90. 7.15.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
  91. 7.16 Northeast Pharmaceutical Group Co., Ltd.
  92. 7.16.1 Northeast Pharmaceutical Group Co., Ltd. Company Information
  93. 7.16.2 Northeast Pharmaceutical Group Co., Ltd. Business Overview
  94. 7.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  96. 7.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Chinese Patent Medicine Market Size by Type
  2. 8.1.1 North America Chinese Patent Medicine Revenue by Type (2021-2032)
  3. 8.1.2 North America Chinese Patent Medicine Sales by Type (2021-2032)
  4. 8.1.3 North America Chinese Patent Medicine Price by Type (2021-2032)
  5. 8.2 North America Chinese Patent Medicine Market Size by Application
  6. 8.2.1 North America Chinese Patent Medicine Revenue by Application (2021-2032)
  7. 8.2.2 North America Chinese Patent Medicine Sales by Application (2021-2032)
  8. 8.2.3 North America Chinese Patent Medicine Price by Application (2021-2032)
  9. 8.3 North America Chinese Patent Medicine Market Size by Country
  10. 8.3.1 North America Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Chinese Patent Medicine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Chinese Patent Medicine Market Size by Type
  2. 9.1.1 Europe Chinese Patent Medicine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Chinese Patent Medicine Sales by Type (2021-2032)
  4. 9.1.3 Europe Chinese Patent Medicine Price by Type (2021-2032)
  5. 9.2 Europe Chinese Patent Medicine Market Size by Application
  6. 9.2.1 Europe Chinese Patent Medicine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Chinese Patent Medicine Sales by Application (2021-2032)
  8. 9.2.3 Europe Chinese Patent Medicine Price by Application (2021-2032)
  9. 9.3 Europe Chinese Patent Medicine Market Size by Country
  10. 9.3.1 Europe Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Chinese Patent Medicine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Chinese Patent Medicine Market Size by Type
  2. 10.1.1 China Chinese Patent Medicine Revenue by Type (2021-2032)
  3. 10.1.2 China Chinese Patent Medicine Sales by Type (2021-2032)
  4. 10.1.3 China Chinese Patent Medicine Price by Type (2021-2032)
  5. 10.2 China Chinese Patent Medicine Market Size by Application
  6. 10.2.1 China Chinese Patent Medicine Revenue by Application (2021-2032)
  7. 10.2.2 China Chinese Patent Medicine Sales by Application (2021-2032)
  8. 10.2.3 China Chinese Patent Medicine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chinese Patent Medicine Market Size by Type
  2. 11.1.1 Asia Chinese Patent Medicine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Chinese Patent Medicine Sales by Type (2021-2032)
  4. 11.1.3 Asia Chinese Patent Medicine Price by Type (2021-2032)
  5. 11.2 Asia Chinese Patent Medicine Market Size by Application
  6. 11.2.1 Asia Chinese Patent Medicine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Chinese Patent Medicine Sales by Application (2021-2032)
  8. 11.2.3 Asia Chinese Patent Medicine Price by Application (2021-2032)
  9. 11.3 Asia Chinese Patent Medicine Market Size by Country
  10. 11.3.1 Asia Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Chinese Patent Medicine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chinese Patent Medicine Market Size by Type
  2. 12.1.1 SAMEA Chinese Patent Medicine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Chinese Patent Medicine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Chinese Patent Medicine Price by Type (2021-2032)
  5. 12.2 SAMEA Chinese Patent Medicine Market Size by Application
  6. 12.2.1 SAMEA Chinese Patent Medicine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Chinese Patent Medicine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Chinese Patent Medicine Price by Application (2021-2032)
  9. 12.3 SAMEA Chinese Patent Medicine Market Size by Country
  10. 12.3.1 SAMEA Chinese Patent Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Chinese Patent Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Chinese Patent Medicine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Chinese Patent Medicine Value Chain Analysis
  2. 13.1.1 Chinese Patent Medicine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Chinese Patent Medicine Production Mode & Process
  6. 13.2 Chinese Patent Medicine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Chinese Patent Medicine Distributors
  9. 13.2.3 Chinese Patent Medicine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst